Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 105890
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.105890
Table 3 Clinical outcomes of the two subgroups of reoperative left lateral sectionectomy
Clinical outcomes
Reoperative open left lateral sectionectomy (n = 40)
Reoperative laparoscopic left lateral sectionectomy (n = 40)
χ²/Z value
P value
Selective hepatic blood flow occlusion5/40 (12.5)8/40 (20.0)0.8270.3631
Operation duration, median (IQR), minute200.0 (180.0-240.0)240.0 (196.3-322.5)-3.0730.0022
Blood loss, median (IQR), mL200.0 (81.3-300.0)200.0 (75.0-281.2)-0.7430.4572
Blood transfusion12/40 (30.0)4/40 (10.0)5.0000.0251
Conversion to open surgery-3/40 (7.5)--
Postoperative intensive care unit stay5/40 (12.5)5/40 (12.5)0.0001.0001
Postoperative hospital stay, median (IQR), days10.0 (8.0-17.0)8.0 (6.0-10.0)-3.3320.0012
Early complications within 90 days16/40 (40.0)17/40 (42.5)0.0520.8201
Major complications within 90 days1/40 (2.5)2/40 (5.0)N/A31.000
Reinterventions within 90 days1/40 (2.5)2/40 (5.0)N/A31.000
Readmission within 90 days5/40 (12.5)6/40 (15.0)0.1050.7451
90-day mortality0/40 (0.0)0/40 (0.0)--
Initial stone clearance rate429/39 (74.4)33/40 (82.5)0.7750.3791
Re-treatment of residual stones44/39 (10.3)2/40 (5.0)N/A30.432
Final stone clearance rate432/39 (85.0)34/40 (85.0)0.1250.7241
Stone recurrence59/32(28.1 )2/34 (5.9)5.8720.0151
Late complications41/39 (2.6)1/40 (2.5)N/A31.000
Late major complications41/39 (2.6)0/40 (0.0)N/A30.494
Secondary ICC44/39 (10.3)1/40 (2.5)N/A30.201
Late death due to complications or ICC44/39 (10.3)1/40 (2.5)N/A30.201